Biliary Atresia Research Network Northeast

计划入组 320 人 · 首次发布于 2023 年 12 月 29 日

Nutritional Intervention for Biliary Atresia

计划入组 120 人 · 首次发布于 2025 年 1 月 8 日

Pentoxifylline Therapy in Biliary Atresia

计划入组 17 人 · 首次发布于 2013 年 1 月 24 日

Biliary tract cancer diagnostic(J-Pharma Co., Ltd.)

NOX inhibitors (primary biliary cholangitis/head and neck cancer)

recombinant angiotensin converting enzyme 2 (ACE-2) gene therapy/AAV vector (biliary fibrosis)

Institute of Liver & Biliary Sciences

India

INSTITUTE OF LIVER AND BILIARY SCIENCES

India

INSTITUTE OF LIVER AND BILIARY SCIENCES, DELHI

India

Ipsen's Phase III BOLD Trial of Bylvay in Biliary Atresia Misses Primary Endpoint

ProQR Doses First Participant in Phase 1 Study of AX-0811

Ipsen Upgrades 2026 Guidance on 23.5% Sales Growth, Positive Phase III Readouts, and Pipeline-Building Acquisitions